2015
Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC
Millman A, Reed C, Kirley P, Aragon D, Meek J, Farley M, Ryan P, Collins J, Lynfield R, Baumbach J, Zansky S, Bennett N, Fowler B, Thomas A, Lindegren M, Atkinson A, Finelli L, Chaves S. Improving Accuracy of Influenza-Associated Hospitalization Rate Estimates - Volume 21, Number 9—September 2015 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2015, 21: 1595-1601. PMID: 26292017, PMCID: PMC4550134, DOI: 10.3201/eid2109.141665.Peer-Reviewed Original ResearchConceptsYears of ageHospitalization ratesAdults 18Test sensitivityLaboratory-confirmed influenza-associated hospitalizationsNational population-based surveillance systemLaboratory-confirmed influenza hospitalizationsPopulation-based surveillance systemInfectious Diseases journal - CDCInfluenza-associated hospitalizationsDiagnostic test typeFluSurv-NETInfluenza hospitalizationsInfluenza seasonPatient ageAge groupsTranscription-PCRAgeHospitalizationDiagnostic test sensitivitySensitive testAdultsSurveillance systemChildrenYearsBurden of Clostridium difficile Infection in the United States
Lessa F, Mu Y, Bamberg W, Beldavs Z, Dumyati G, Dunn J, Farley M, Holzbauer S, Meek J, Phipps E, Wilson L, Winston L, Cohen J, Limbago B, Fridkin S, Gerding D, McDonald L. Burden of Clostridium difficile Infection in the United States. New England Journal Of Medicine 2015, 372: 825-834. PMID: 25714160, PMCID: PMC10966662, DOI: 10.1056/nejmoa1408913.Peer-Reviewed Original ResearchConceptsClostridium difficile infectionDifficile infectionFirst recurrenceHealth care-associated infectionsCommunity-associated infectionsC. difficile infectionCare-associated infectionsPersons 65 yearsLaboratory-based surveillanceType 1 strainsNumber of deathsNational incidenceMolecular typingC. difficileInfectionIncidenceDeathUnited StatesRecurrenceGeographic areasSample of casesEstimated numberRegression modelsActive populationHealth
2013
Complications and Associated Bacterial Coinfections Among Children Hospitalized With Seasonal or Pandemic Influenza, United States, 2003–2010
Dawood F, Chaves S, Pérez A, Reingold A, Meek J, Farley M, Ryan P, Lynfield R, Morin C, Baumbach J, Bennett N, Zansky S, Thomas A, Lindegren M, Schaffner W, Finelli L, Network F. Complications and Associated Bacterial Coinfections Among Children Hospitalized With Seasonal or Pandemic Influenza, United States, 2003–2010. The Journal Of Infectious Diseases 2013, 209: 686-694. PMID: 23986545, DOI: 10.1093/infdis/jit473.Peer-Reviewed Original ResearchConceptsIntensive carePandemic influenzaLaboratory-confirmed influenza hospitalizationsBacteremia/sepsisInfluenza-associated complicationsIntensive care requirementAcute renal failurePopulation-based surveillanceSeverity of complicationsMedian hospitalization durationNinth Revision codesInfluenza hospitalizationsAsthma exacerbationsHospitalization durationInfluenza vaccinationRespiratory failureCommon complicationRenal failureBacterial coinfectionProlonged hospitalizationMedian lengthPrimary preventionRevision codesSeasonal influenzaHospitalized children
2012
Guillain-Barré Syndrome During the 2009–2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans
Wise M, Viray M, Sejvar J, Lewis P, Baughman A, Connor W, Danila R, Giambrone G, Hale C, Hogan B, Meek J, Murphree R, Oh J, Reingold A, Tellman N, Conner S, Singleton J, Lu P, DeStefano F, Fridkin S, Vellozzi C, Morgan O. Guillain-Barré Syndrome During the 2009–2010 H1N1 Influenza Vaccination Campaign: Population-based Surveillance Among 45 Million Americans. American Journal Of Epidemiology 2012, 175: 1110-1119. PMID: 22582209, PMCID: PMC3888111, DOI: 10.1093/aje/kws196.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedChildChild, PreschoolFemaleGuillain-Barre SyndromeHealth PromotionHumansIncidenceInfantInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanMaleMiddle AgedPopulation SurveillanceProduct Surveillance, PostmarketingRisk AssessmentTime FactorsUnited StatesYoung AdultConceptsGuillain-Barré syndromePopulation-based surveillanceGBS casesPH1N1 vaccineInfluenza A (H1N1) 2009 monovalent vaccineRate of GBSEmerging Infections Program sitesSex-adjusted rate ratiosH1N1 influenza vaccineMedical record reviewVaccine coverage dataInfluenza vaccination campaignGBS incidencePH1N1 vaccinationInfluenza vaccineMonovalent vaccineRecord reviewIncident casesVaccine dosesExcess riskPatient interviewsGBS riskVaccine campaignVaccine historyVaccination campaignInfluenza-associated Hospitalizations by Industry, 2009–10 Influenza Season, United States - Volume 18, Number 4—April 2012 - Emerging Infectious Diseases journal - CDC
Luckhaupt SE, Sweeney MH, Funk R, Calvert GM, Nowell M, D'Mello T, Reingold A, Meek J, Yousey-Hindes K, Arnold KE, Ryan P, Lynfield R, Morin C, Baumbach J, Zansky S, Bennett NM, Thomas A, Schaffner W, Jones T. Influenza-associated Hospitalizations by Industry, 2009–10 Influenza Season, United States - Volume 18, Number 4—April 2012 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2012, 18: 556-562. PMID: 22469504, PMCID: PMC3309704, DOI: 10.3201/eid1804.110337.Peer-Reviewed Original Research
2011
Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study
Vandermeer M, Thomas A, Kamimoto L, Reingold A, Gershman K, Meek J, Farley M, Ryan P, Lynfield R, Baumbach J, Schaffner W, Bennett N, Zansky S. Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study. The Journal Of Infectious Diseases 2011, 205: 13-19. PMID: 22170954, DOI: 10.1093/infdis/jir695.Peer-Reviewed Original ResearchConceptsEmerging Infections ProgramLaboratory-confirmed influenzaInfluenza virus infectionVirus infectionPrevention's Emerging Infections ProgramMultivariable logistic regression modelInfluenza-related deathsChronic lung diseaseUse of statinsAdministration of statinsRisk of mortalityLogistic regression modelsProtective oddsHospitalized adultsInfluenza testsInfluenza vaccinationStatin useInfluenza seasonRenal diseaseAntiviral administrationImmunomodulatory effectsLung diseaseActive surveillanceInfections ProgramStatins
2009
Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study
Connally NP, Durante AJ, Yousey-Hindes KM, Meek JI, Nelson RS, Heimer R. Peridomestic Lyme Disease Prevention Results of a Population-Based Case–Control Study. American Journal Of Preventive Medicine 2009, 37: 201-206. PMID: 19595558, DOI: 10.1016/j.amepre.2009.04.026.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAnimalsCase-Control StudiesChildChild, PreschoolConnecticutEnvironment DesignEnvironmental ExposureFemaleHumansHygieneInfantLogistic ModelsLyme DiseaseMaleMatched-Pair AnalysisMiddle AgedPopulation SurveillanceProspective StudiesResidence CharacteristicsRisk FactorsSurveys and QuestionnairesTicksYoung AdultConceptsCase-control studyLyme diseaseDisease prevention initiativesConditional logistic regressionDisease prevention measuresErythema migransPotential confoundersRecreational exposureLogistic regressionProspective ageDiseaseCase onsetPrevention resultsPrevention measuresPersonal protectionRiskHoursConfoundersMigransTicksInfectionStudyConnecticut communitiesMonths
2008
The mortality burden of chronic liver disease may be substantially underestimated in the United States.
Durante AJ, St Louis T, Meek JI, Navarro VJ, Sofair AN. The mortality burden of chronic liver disease may be substantially underestimated in the United States. Connecticut Medicine 2008, 72: 389-92. PMID: 18763665.Peer-Reviewed Original ResearchConceptsChronic liver diseaseICD-10 codesLiver diseaseEnd-stage liver diseaseStage liver diseaseDeath certificate dataCause of deathMedical examiner recordsCLD burdenCLD statusMedical chartsMortality burdenDeath certificatesCertificate dataHealth StatisticsCounty residentsDiseaseGold standardBurdenSerious diseaseDeathUnited States National CenterDetrimental effectsSpecificityPrevention
2001
Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut.
Kluger M, Sofair A, Heye C, Meek J, Sodhi R, Hadler J. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut. American Journal Of Public Health 2001, 91: 1214-9. PMID: 11499106, PMCID: PMC1446748, DOI: 10.2105/ajph.91.8.1214.Peer-Reviewed Original ResearchConceptsActive prospective surveillanceInfectious causesUnexplained illnessProspective surveillanceRetrospective surveillanceRetrospective validationProspective surveillance systemHospital discharge dataSurveillance systemSuch patientsAnnual incidenceStudy criteriaMedical recordsNew Haven CountyComputerized searchIllnessLess labor-intensive alternativeDeathLabor-intensive alternativePatientsReference populationSurveillanceCauseDischarge dataStudy counties
1996
Underreporting of Lyme Disease by Connecticut Physicians, 1992
Meek J, Roberts C, Smith E, Cartter M. Underreporting of Lyme Disease by Connecticut Physicians, 1992. Journal Of Public Health Management And Practice 1996, 2: 61-65. PMID: 10186700, DOI: 10.1097/00124784-199623000-00017.Peer-Reviewed Original ResearchMeSH KeywordsConnecticutDisease NotificationHumansIncidenceLyme DiseasePhysiciansPopulation SurveillanceReproducibility of Results